Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Curagen Corp (CRGN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Curagen Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1030653.
Total stock buying since 2005: $322,850.
Total stock sales since 2005: $1,268,354.
Total stock option exercises since 2005: $74,778.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 220,546 | $247,434 | 108,374 | $74,778 |
| 2008 | 0 | $0 | 23,000 | $16,836 | 0 | $0 |
| 2007 | 90,000 | $208,800 | 341,170 | $908,964 | 0 | $0 |
| 2006 | 0 | $0 | 7,301 | $30,810 | 0 | $0 |
| 2005 | 25,000 | $114,050 | 10,000 | $64,310 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-09 | 0 | $0 | 172,124 | $179,770 | 108,374 | $74,778 |
| 2009-08 | 0 | $0 | 48,422 | $67,664 | 0 | $0 |
| 2008-02 | 0 | $0 | 23,000 | $16,836 | 0 | $0 |
| 2007-08 | 30,000 | $39,900 | 0 | $0 | 0 | $0 |
| 2007-05 | 60,000 | $168,900 | 37,170 | $101,845 | 0 | $0 |
| 2007-04 | 0 | $0 | 304,000 | $807,119 | 0 | $0 |
| 2006-12 | 0 | $0 | 7,301 | $30,810 | 0 | $0 |
| 2005-08 | 25,000 | $114,050 | 10,000 | $64,310 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-09-24 | Finigan Paul M (EVP & General Counsel) | Sale | 51,850 | 1.34 | 69,479 |
| 2009-09-23 | Finigan Paul M (EVP & General Counsel) | Sale | 120,274 | .92 | 110,291 |
| 2009-09-23 | Finigan Paul M (EVP & General Counsel) | Option Ex | 108,374 | .69 | 74,778 |
| 2009-08-14 | Finigan Paul M (EVP & General Counsel) | Sale | 37,500 | 1.39 | 51,937 |
| 2009-08-07 | Finigan Paul M (EVP & General Counsel) | Sale | 10,922 | 1.44 | 15,727 |
| 2008-02-11 | Armstrong Frank M (Director) | Sale | 23,000 | .73 | 16,836 |
| 2007-08-10 | Whayland Elizabeth A (SVP of Finance, Secretary) | Buy | 30,000 | 1.33 | 39,900 |
| 2007-05-15 | Wurzer David M (EVP, CFO, Treasurer) | Sale | 7,000 | 2.74 | 19,180 |
| 2007-05-14 | Wurzer David M (EVP, CFO, Treasurer) | Sale | 30,170 | 2.74 | 82,665 |
| 2007-05-08 | Noble James (Director) | Buy | 20,000 | 2.87 | 57,400 |
| 2007-05-07 | Zenner Patrick J (Director) | Buy | 10,000 | 2.75 | 27,500 |
| 2007-05-03 | Forsgren John H (Director) | Buy | 5,000 | 2.80 | 14,000 |
| 2007-05-03 | Patricelli Robert E (Director) | Buy | 25,000 | 2.80 | 70,000 |
| 2007-04-30 | Rothberg Jonathan M (10% Owner) | Sale | 304,000 | 2.65 | 807,119 |
| 2006-12-11 | Rothberg Jonathan M (Director) | Sale | 7,301 | 4.22 | 30,810 |
| 2005-08-18 | Patricelli Robert E (Director) | Buy | 25,000 | 4.56 | 114,050 |
| 2005-08-01 | Whayland Elizabeth A (VP of Finance, Secre) | Sale | 10,000 | 6.43 | 64,310 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Curagen Corp (symbol CRGN, CIK number 1030653) see the Securities and Exchange Commission (SEC) website.